A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder

CONCLUSION: The results from this systematic review will aid in highlighting significant genetic variants that can be replicated in future OUD pharmacogenetics research to ascertain their role in patient-specific MOUD outcomes. Systematic review registration number CRD42020169121.PMID:34838141 | PMC:PMC8627063 | DOI:10.1186/s13722-021-00278-y

Source: Addiction Science and Clinical Practice - November 28, 2021 Category: Addiction Authors: Caroul Chawar Alannah Hillmer Stephanie Sanger Alessia D'Elia Balpreet Panesar Lucy Guan Dave Xiaofei Xie Nandini Bansal Aamna Abdullah Flavio Kapczinski Guillaume Pare Lehana Thabane Zainab Samaan Source Type: research